Cerity Partners’s Adtran ADTN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$247K Sell
17,786
-2,005
-10% -$31.3K ﹤0.01% 2928
2026
Q1
$249K Buy
+19,791
New +$201K ﹤0.01% 2743
2025
Q4
Sell
-10,495
Closed -$98.4K 2874
2025
Q3
$98.4K Buy
+10,495
New +$97.8K ﹤0.01% 2629
2025
Q2
Sell
-15,705
Closed -$137K 2629
2025
Q1
$137K Buy
+15,705
New +$158K ﹤0.01% 2280
2024
Q2
Sell
-20,062
Closed -$109K 2224
2024
Q1
$109K Buy
+20,062
New +$128K ﹤0.01% 2200

Other funds holding ADTN

Cerity Partners's ADTN Position: Q2 2026 in Review

Cerity Partners reduced its Adtran (ADTN) stake by 10% in Q2 2026, selling an estimated $31.3K and leaving 17,786 shares worth $247K. The position accounts for ﹤0.01% of the portfolio, ranked #2928.

Cerity Partners first reported a position in ADTN in Q1 2024 and has held it in 5 quarters since. The position peaked at $249K in Q1 2026. 213 funds tracked by Wall St. Rank hold ADTN as of Q2 2026.

  • Cerity Partners held 17,786 shares of Adtran worth $247K as of Q2 2026.
  • Cerity Partners sold 2,005 Adtran shares in Q2 2026, an estimated $31.3K.
  • Adtran made up ﹤0.01% of Cerity Partners's portfolio in Q2 2026, its #2928 holding.
  • Cerity Partners first reported a position in Adtran in Q1 2024 and has held it in 5 quarters since.
  • Cerity Partners's Adtran position peaked at $249K in Q1 2026.
  • 213 funds tracked by Wall St. Rank held Adtran as of Q2 2026.

Based on Cerity Partners's 13F filing for Q2 2026, filed 14 Aug 2026.